A comprehensive repertoire of tRNA-derived fragments in prostate cancer
Abstract
This article has supplementary files, which can be found here:http://dx.doi.org/10.18632/oncotarget.8293
Full text
Onco a ge 24766
www.impac jou nals.com/onco a ge
www.impac jou nals.com/onco a ge / Onco a ge , Vol. 7, No. 17
A comp ehensi e epe oi e o RNA-de i ed agmen s in
p os a e cance
Michael Ol edy1,4,5,*, Mau o Sca a illi2,3,*, You i Hoogs a e1, Tapio Visako pi2,3,#,
Guido Jens e 1,#, Elena S. Ma ens-Uzuno a1,#
1Depa men o U ology, E asmus MC, Ro e dam, The Ne he lands
2Ins i u e o Biosciences and Medical Technology-BioMediTech, Uni e si y o Tampe e, Tampe e, Finland
3Fimlab Labo a o ies, Tampe e Uni e si y Hospi al, Tampe e, Finland
4 Cu en add ess: VIB Cen e o he Biology o Disease, KU Leu en, Leu en, Belgium
5Cu en add ess: Cen e o Human Gene ics, KULeu en, Leu en, Belgium
*These au ho s con ibu ed equally o his wo k
#Th ee las au ho s con ibu ed equally o his wo k
Co espondence o: Elena S. Ma ens-Uzuno a, e-mail: [email p o ec ed]
Keywo ds: RNA-de i ed agmen s ( RFs), p os a e cance (PCa), RNA-sequencing, non-coding RNA, bioma ke
Recei ed: Sep embe 04, 2015 Accep ed: Ma ch 02, 2016 Published: Ma ch 23, 2016
ABSTRACT
P os a e cance (PCa) is he mos common cance among men in de eloped
coun ies. Al hough i s gene ic backg ound is ho oughly in es iga ed, a he li le
is known abou he ole o small non-coding RNAs (sncRNA) in his disease. RNA-
de i ed agmen s ( RFs) ep esen a new class o sncRNAs, which a e p esen in
a b oad ange o species and ha e been epo ed o play a ole in se e al cellula
p ocesses. He e, we analyzed he exp ession o RFs in esh ozen pa ien samples
de i ed om no mal adjacen p os a e and di e en s ages o PCa by RNA-sequencing.
We iden i ied 598 unique RFs, many o which a e de egula ed in cance samples when
compa ed o no mal adjacen issue. Mos o he iden i ied RFs a e de i ed om he
5’- and 3’-ends o ma u e cy osolic RNAs, bu we also ound RFs p oduced om
o he pa s o RNAs, including p e- RNA aile s and leade s, as well as RFs om
mi ochond ial RNAs. The 5’-de i ed RFs comp ise he mos abundan class o RFs in
gene al and ep esen he majo class among up egula ed RFs. The 3’-de i ed RFs
ypes a e dominan among down egula ed RFs in PCa. We alida ed he exp ession
o h ee RFs using qPCR. The a io o RFs de i ed om RNALysCTT and RNAPheGAA
eme ged as a good indica o o p og ession- ee su i al and a candida e p ognos ic
ma ke . This s udy p o ides a sys ema ic ca alogue o RFs and hei dys egula ion
in PCa and can se e as he basis o u he esea ch on he bioma ke po en ial and
unc ional oles o RFs in his disease.
INTRODUCTION
P os a e cance (PCa) is he second mos
common cance in men wo ldwide [1]. The ea men
o PCa is hampe ed by he lack o eliable ma ke s o
disease ou come p edic ion leading o inco ec pa ien
s a i ica ion, o e ea men and consequen side e ec s
om p os a ec omy and adia ion he apy [2]. A be e
unde s anding o he molecula mechanisms behind
he onse and p og ession o PCa is needed in o de o
disco e be e ma ke s and de elop new he apeu ic
s a egies. The ole o small non-coding RNAs (sncRNAs)
o he han mic oRNAs (miRNAs) in PCa is poo ly
unde s ood. The apid p og ess and popula i y o high
h oughpu sequencing led o he disco e y o a no el
class o sncRNAs de i ed om RNAs and named RNA-
de i ed agmen s ( RFs) [3–5]. RFs a e p esen ac oss all
domains o li e [6–8]. While ini ially conside ed andom
p oduc s o RNA u no e , hei abundance and ubiqui ous
exp ession sugges ha RFs a e ac ual biological en i ies
[6, 7].
RFs can be gene a ed by endonucleases such as
ibonuclease T2 (Rny1p) in yeas and angiogenin o dice 1
in human. Based on size, hey a e di ided in o wo g oups.
Onco a ge 24767
www.impac jou nals.com/onco a ge
The i s g oup consis s o RFs wi h a size o 30 o 35 n ,
which a e gene ally e e ed o as RNA hal es o s ess-
induced RFs. RNA hal es a e p oduced by endonucleoly ic
clea age a he an icodon loop o he ull-leng h RNA. The
second g oup consis s o RFs wi h a size o abou 20 n
and can be u he di ided in o 5’- and 3’-de i ed RFs,
o igina ing om he 5′- and 3′-pa s o ma u e RNAs,
espec i ely [4, 9, 10]. The small RNAs de i ed om he
5’-leade and 3’- aile sequences o he p ecu so RNAs
(p e- RNAs) a e also classi ied as RFs [5, 11, 12].
Exp ession o RFs is de ec ed in di e en cance
cell lines, including he PCa cell lines LNCaP and C4-2 [4,
5, 13–15]. In a p e ious s udy, we epo ed he disco e y
and di e en ial exp ession o RFs in clinical samples o
PCa [16]. This sugges s ha RFs migh play an impo an
ole in he pa hogenesis o cance . The mechanism behind
he unc ion o RFs appea s o be di e se. Se e al epo s
demons a e ha RF le els a e ele a ed by cellula
s ess condi ions and pa icula ly unde oxida i e s ess
such as hypoxia [10, 13, 15, 17]. RFs a e also in ol ed
in pos - ansc ip ional egula ion o gene exp ession ia
di ec inhibi ion o p o ein syn hesis by displacing he
eIF4G ansla ion ini ia ion ac o om mRNA [18–20].
Mo eo e , a 3′-de i ed RF iden i ied in B-cell lymphoma
cells possesses he unc ional cha ac e is ics o a guide
RNA ha supp esses p oli e a ion and modula es esponse
o DNA damage in a miRNA- ashion [21]. I has also
been shown ha RFs can compe e o he binding si es
o he RNA-binding p o ein YBX1, which is in ol ed in
he s abiliza ion o oncogenic ansc ip s supp essing cell
g ow h and in asion [15]. In his way, RFs an agonize
he ac i i y o YBX1 and ac as umo supp esso s. Taken
oge he , hese indings s ongly sugges a unc ional ole
o RFs in umo igenesis.
Ve y ecen ly, i was p oposed ha al hough RFs
a e de ined biological en i ies, hei composi ion and
abundance in he ansc ip ome is dependen on gende ,
issue, disease and e en disease sub ype [22]. This
sugges s ha RFs can be explo ed as no el sensi i e
bioma ke s o disease. Ye , s udies p o iding sys ema ic
insigh in o he composi ion and exp ession o he RF
ansc ip ome h oughou a ious disease s ages a e s ill
missing. He e, we analyze RF exp ession in an ex ended
coho o clinical samples ep esen ing p og essing s ages
o PCa. We cons uc a da abase o RFs exp essed ac oss
PCa samples and iden i y he mos di e en ially exp essed
RFs. Finally, we pe o m a qPCR quan i ica ion in wo
coho s o clinical samples o alida e he di e en ial
exp ession o selec ed RFs.
RESULTS
In en o y o RFs exp essed in PCa
In o de o ob ain a global o e iew o he RF
epe oi e in PCa, we analyzed RFs ac oss no mal
adjacen p os a e (NAP), benign-p os a e hype plasia
(BPH), PCa om adical p os a ec omies, ans-u e h al
esec ed issue om cas a ion esis an PCa (TURP_
PCa), and lymph node me as asis (LN_PCa) using nex -
gene a ion RNA sequencing (Table 1).
All 21 cy osolic RNA iso ypes (including
selenocys ein RNAs) we e ound o p oduce RFs in
a iable amoun s (Figu e 1A). RNAAla and RNALys
showed he highes numbe s o mapped RFs, while he
leas RFs we e p oduced om RNA
Ile
and RNA
Asp
. The
aw sum o RFs weakly co ela ed wi h he numbe o
RNA genes pe iso ype o an icodon, as well as wi h
he pe cen age o codon usage (Supplemen a y Figu e
1; codon usage om h p://g nadb.ucsc.edu/Hsapi19/
Hsapi19-summa y-codon.h ml). RFs de i ed om 15 ou
o 20 mi ochond ial RNAs (m RNAs) we e also de ec ed
(Figu e 1A). We could no de ec RFs co esponding o
he mi ochond ial RNA iso ypes m RNAGln, m RNAGlu,
m RNALys, m RNAT p and m RNAVal. Wi h he excep ion
o m RNA
Phe
, mos m RNA iso ypes had a lowe numbe
o mapped RFs, compa ed o cy osolic RNAs. The ead
coun o m RNAPhe in he NAP g oup was 83- old highe
han he a e age o all o he m RNA ead coun s.
In o de o quan i y he exp ession o RFs, we
assembled a PCa RF-da abase using he agmen
de ec ion algo i hm FlaiMappe [23]. The ead-co e age o
ma u e cy oplasmic RNAs ac oss all g oups was analyzed
using CLC-Bio Genomics Wo kbench. Ini ially, 1175
RFs we e iden i ied and mapped o 386 unique cy osolic
RNAs [24]. Howe e , since RNA sequences a e highly
conse ed wi hin RNA iso ypes, some RFs we e mapped
o mo e han one unique RNA (Supplemen a y Figu e 2)
and he o al ead-coun in he ini ial mapping was equally
di ided ac oss hem. Upon u he examina ion, we
no iced ha his causes unde ep esen a ion o sequence
coun s o RFs ha had iden ical sequence bu could
be mapped o mul iple RNA iso ypes. The e o e, RFs
wi h iden ical sequences we e me ged in o single en ies,
e en i hey could be de i ed om di e en RNAs,
and hei co esponding eads we e summed. A e his
co ec ion, a o al o 598 unique RFs we e iden i ied
(Supplemen a y Table 1). Mul iple agmen a ion pa e ns,
in combina ion wi h low ead-coun , caused low eliabili y
in he au oma ed p edic ion o RFs de i ed om m RNAs
(Supplemen a y Figu e 3). The e o e, hese RFs we e
omi ed om u he analysis.
Based on hei size, RNA-de i ed agmen s can
be gene ally sepa a ed in o wo majo ca ego ies: RNA
hal es, wi h a size o 30-35 n and small RNA agmen s
( RFs), wi h a size o app oxima ely 20 n . In ou da ase ,
small RFs we e p edominan and hei sizes anged
om 15 o 23 n (Figu e 1B). The mos abundan RFs,
howe e , we e be ween 18 o 21 n , while 40% o RFs
we e 19 n long (Figu e 1B). A g oup o longe RFs, wi h
sizes be ween 25 and 29 n , was also iden i ied.
In addi ion o RFs de i ed om ma u e RNAs, we
we e also able o de ec agmen s co esponding o he
5’-p e- RNA leade (5’U- RFs) and 3’-p e- RNA aile
Onco a ge 24768
www.impac jou nals.com/onco a ge
(3’U- RFs) sequences o a ious RNAs (Supplemen a y
Table 2). The leng h o 5’U- RFs and 3’U- RFs a ied
be ween 15 and 25 n . Mos 5’U- RFs we e 17 n long and
mos 3’U- RFs we e 18 n long (Supplemen a y Figu e
4A). In e es ingly, mo e han 54% o 3’U- RFs and 30% o
5’U- RFs we e de i ed om sequences igh nex o o 1
n away om he ma u e RNA sequence (Supplemen a y
Figu e 4B-4C), sugges ing ha hey a e p oduced du ing
he no mal p ocessing o p e- RNA. Bo h 5’U- RFs and
3’U- RFs showed o e all low exp ession alues (da a
no shown), wi h he excep ion o RF-1001/cand45. This
agmen was p e iously de ec ed in PCa cell lines, as
well as in human colon ca cinoma and human emb yonic
kidney cells [5, 11]. In ou lib a ies RF-1001/cand45
showed ead coun s om 40 000 in he NAP and PCa
(a e age) g oups o 110 000 in he LN_PCa g oup.
RFs de i ed om he 5’-end a e dominan in PCa
The majo i y o RFs iden i ied in ou samples
o igina e om he 5′- and he 3′-end o RNAs (Figu e 1C).
This is in conco dance wi h p e ious s udies collec i ely
epo ing on he exis ence o sho RFs de i ed om he
5′- and he 3′-end o ma u e RNAs [5, 25, 26]. To analyze
he ela i e abundance o each RF class in ou da ase we
examined he s a and end posi ions o all unique RFs
on hei p ecu so RNAs. All he agmen s wi h a 3’-end
nucleo ide a posi ion ≤40 on he ma u e RNA sequence
we e conside ed as 5′-de i ed, whe eas all agmen s wi h
he i s 5’-nucleo ide a posi ion ≥30 on he ma u e RNA
sequence we e conside ed as 3′-de i ed. Based on agmen
uniqueness, we ound compa able a es o RF ypes, i.e.
51.7% co esponded o 5′-de i ed RFs and 44.2% o
3′-de i ed RFs. Ne e heless, when ela i e agmen
abundance was aken in o accoun a s ong bias owa ds he
5′-de i ed (84.7%) s. he 3’-de i ed RFs was obse ed.
To ge a mo e p ecise o e iew o he localiza ion
o RFs, we also analyzed hei s a - and end- posi ion
equencies. In e es ingly, mo e han 26% o all unique
RFs, which in he e ms o abundance accoun o o e
80% o all RFs, we e ound o s a a posi ion 1 on he
ma u e RNA sequence (Figu e 1D–1E). Mos o hese
Table 1: Clinical pa ame e s o he samples used o he RNA-sequencing
G oup
name
Pa ien
samples
TMPRSS2_
ERG usion
ETV1
abe a ions
Cance
cells (%)
Gleason
sco e
P eope a i e
PSA Mean
(Min.-
Max.)
S a us a e
adical
p os a ec omy*
NAP 4 0 (0%) 0 0 N/A 5.8 (2.5 - 11) N/A
BPH 4N/A N/A 0N/A N/A N/A
PCa6_cu 4 4 (100%) 0 70-90 3+3 3.8 (2.0 -
7.2) Cu ed
PCa6_
no usion 4 0 (0%) 0 70-90 3+3 10.8 (0.5 -
23.7) Recu en
PCa6_
TERG 4 4 (100%) 0 80-90 3+3 7.3 (2.0 -
10.5) Recu en
PCa6_ ecu 4 4 (100%) 0 80-90 3+3 11.3 (6.0 -
64.3) Recu en
PCa7_ ecu 4 2 (50%) 1 ( usion) 80-100 4+3 25.2 (6.5 -
64.3) Recu en
PCa8_ ecu 3 1 (25%) 1
(o e exp essed) 90-100 4+4 (5) 32.4 (31.9 -
32.9) Recu en
TURP_PCa
(cas a ion
esis an )
4 1 (25%) 1 ( usion) 90-100 (3+4) o
(5+4) Unknown Recu en
LN_PCa 4 3 (75%) 1 ( usion) 100 4+4(5)† 154.6 (80.2 -
252.5) N/A
* Pa ien s we e conside ed cu ed i he e was no biochemical elapse o de ec ion o me as asis a e adical p os a ec omy
† Gleason sco e o he p ima y umo
G oup abb e ia ions: NAP, no mal adjacen p os a e; BPH, benign p os a ic hype plasia; PCa, o gan-con ined p os a e
cance ; cu / ecu , cu ed/ ecu en a e adical p os a ec omy; PCa6_no usion, PCa Gleason sco e 3+3 wi h no TMPRSS2-
ERG usion o ETV abno mali ies; PCa6_TERG, PCa Gleason sco e 3+3 wi h TMPRSS2-ERG usion; TURP_PCa, ans-
u e h al esec ion o he p os a e, cas a ion esis an PCa; LN_PCa, lymph node me as asis.
Onco a ge 24769
www.impac jou nals.com/onco a ge
RFs ha e he end a posi ion 19 on he ma u e RNA.
Based on he peaks gene a ed by he s a posi ions o all
unique agmen s (Figu e 1D), we obse ed ha he RF
pool cons i u es o se e al dis inc classes (no e he peak
appea ing be o e 20 n , ano he a a ound 40 n and ano he
be o e 60 n o he ma u e RNA). While ca ego izing RFs
in o 5′- o 3′-de i ed RFs is e y common, we ound ha
a leas 5 di e en classes a e p esen ac oss ou samples.
The e o e, we classi ied RFs in o (i) 5e- RFs wi h a s a
posi ion in he i s nucleo ide o he 5’-end o he RNA
(“e” s ands o “end”); (ii) D- RFs wi h a s a posi ion
be ween nucleo ides 12-23 and o e lapping he D-loop
o he p ecu so - RNA; (iii) A- RFs s a ing be ween
nucleo ides 31-39 and o e lapping wi h he an icodon
loop; (i ) V- RFs wi h a s a be ween nucleo ides 45-49
and o e lapping he a iable loop; and inally, ( ) 3e- RFs
s a ing be ween nucleo ides 50-60 and o e lapping he
T loop (Figu e 1F). While 5e- RFs ep esen he mos
abundan class o RFs (app oxima ely 75%), o he
classes o RFs appea o ha e e y simila exp ession
(<10% abundance) compa ed o each o he (Figu e 1G).
In e es ingly, simila RF ypes ha e been de ec ed in he
Figu e 1: RF ypes in p os a e cance . A. Hea map showing he o al ead coun s mapped o indi idual RNA iso ypes in h ee s udy
g oups: NAP, no mal adjacen p os a e; PCa, p os a e cance g oup (consis ing o 6 di e en sample pools, he a e age alue is shown);
LN_PCa, lymph node me as asis. The colo and i s co esponding alue in log10 scale a e depic ed on he igh . B. RF leng h as based
on he ead abundance (o ange ba s) and uniqueness (do ed line). C. G aph depic ing he loca ions o mapped RFs on he sequences
o ma u e RNAs. Full-leng h RNA sequences a e aligned o he middle using he an icodon posi ion. RFs mapped o hese RNAs a e
depic ed as g ey ba s which ela i e abundance pe pa icula RNA is e lec ed by he colo in ensi y (ligh g ey, low abundance; black,
high abundance). RNAs wi h only one mapped RF a e clus e ed a he op, RNAs wi h wo mapped RFs in he middle and RNAs wi h
mul iple mapped RFs a e a he bo om. D-E. S a (blue line) and end (o ange line) posi ions o RFs on he ma u e RNA sequence.
Rela i e abundance o each RF s a and end based on he uniqueness (D) o abundance (E) is shown. F. An illus a ion o a ious RF
ypes and hei app oxima e loca ion on he seconda y s uc u e o RNA. G. Rela i e p opo ions o each RF ypes in ou da ase as based
on he uniqueness (% o unique independen eads) o abundance (% o o al numbe o eads).
Onco a ge 24770
www.impac jou nals.com/onco a ge
lowe euka yo e Te ahymena he mophile, sugges ing he
exis ence o an e olu iona y conse ed RNA p ocessing
mechanisms [27]. Mo eo e , he posi ion o hese peaks
was ound o o e lap wi h all RNA loops, indica ing ha
endonucleoly ic clea age occu s in he single-s anded
loop egions o RNAs.
Se e al RFs a e de egula ed in PCa
To in es iga e whe he RF p oduc ion is
dys egula ed in PCa, we compa ed he exp ession le els
o RFs in no mal issue and in samples om di e en
clinical s ages ep esen ing p og essing disease (Table
1). While exp ession le els o o he ypes o sncRNAs
co ela ed well be ween he wo lib a ies ep esen ing
non-malignan issue, i.e. NAP and BPH (Pea son =0.89,
P- alue <0.0001; median old-change -0.002), RFs
showed lowe co ela ion and a e y high one-di ec ional
de ia ion owa ds inc eased exp ession in he BPH lib a y
(Pea son =0.81; P- alue <0.0001; median old-change
0.758; Supplemen a y Figu e 5). These esul s indica e ha
RFs, as opposed o o he sncRNAs, migh be di e en ially
exp essed in benign p os a e hype plasia. This di e ence
can be explained by he di e en ana omical o igin o
he BPH and NAP/PCa samples. While BPH occu s
exclusi ely in he ansi ion zone o he p os a e, p os a e
umo s a e p edominan ly localized in he pe iphe al zone.
Bo h zones a e cha ac e ized by dis inc exp ession p o iles
indica ing di e en ial egula ion o a la ge numbe o
genes [28]. Fo his eason, BPH was excluded as a con ol
sample om u he analyses. Only NAP issue, con i med
o con ain 0% umo cells by wo independen pa hologis s,
was used as a con ol sample. I should be acknowledged,
ha adjacen issue could be al e ed in gene/ncRNA
exp ession due o umo -s oma pa ac ine in luences [29].
Ne e heless, as much as s oma/epi helium in e ac ions
a e una oidable in expe imen s we e samples a e de i ed
by mac o-dissec ion, much ca e has been aken o minimize
he in luence o he s omal compa men on he exp ession
p o iles o small RNAs by selec ing issue sec ions o a
leas 70% epi helial cells [24].
We ound se e al RFs o be signi ican ly
di e en ially exp essed in PCa when compa ed o NAP
(Kal’s Z- es wi h Bon e oni co ec ion, p- alue < 0.05)
(Figu e 2 and Supplemen a y Table 3-4). The numbe o
di e en ially exp essed RFs a ied sligh ly be ween
he s ages o PCa, wi h a minimum o 27 di e en ially
exp essed RFs in PCa6_ ecu g oup and a maximum o
61 di e en ially exp essed RFs in he LN_PCa g oup
(Figu e 2, Supplemen a y Table 4). We iden i ied 12 RFs
o be commonly di e en ially exp essed be ween ecu en
PCa g oups wi h Gleason g ade 6, 7, o 8 (Supplemen a y
Table 5). O hese, 5 we e up egula ed, 6 down egula ed
and 1 was down egula ed in PCa6 g oup bu up egula ed in
PCa7 and PCa8 g oups (Supplemen a y Table 5). This esul
indica es ha a small subse o di e en ially exp essed RFs
can be ound ac oss inc easing g ades o PCa.
In summa y, we ound 110 di e en ially exp essed
RFs ac oss ou da ase , ou o which 72 we e up egula ed,
24 down egula ed and 13 ha we e up egula ed in one bu
down egula ed in o he g oup.
RFs de egula ed in PCa belong o dis inc
classes
I has been p oposed ha 5′- bu no 3′-de i ed
RFs, play a ole in s ess g anule assembly o inhibi ion
o p o ein syn hesis in i o [19, 30]. On he o he hand,
some 3′-de i ed RFs a e able o ep ess hei mRNA
a ge s in a miRNA-like ashion and may exe umo
supp essi e unc ions [21, 31]. In e es ingly, ou esul s
indica e ha he de egula ion o 5’-de i ed RFs di e s
om ha o 3’-de i ed RFs (Figu e 2). In o de o s udy
which RF ypes a e p esen among he down egula ed
and up egula ed RFs in PCa we compa ed he pe cen age
o di e en RF ypes among ou g oups o up egula ed
and down egula ed RFs (Figu e 3A–3B). We no iced
majo di e ences in he abundance o RF ypes in
bo h lis s. Mos o he up egula ed RFs we e 5e- RFs
(50%) and mos down egula ed we e 3e- RFs (50%).
We selec ed RFs o igina ing om 6 di e en RNAs o
u he analysis and qPCR alida ion. All o hem we e
commonly di e en ially egula ed in ecu en PCa g oups
wi h Gleason g ade 6, 7, o 8 (Supplemen a y Table 5).
Ou o hese, 4 RFs ( h ee 5e- RFs and one D- RF) we e
up egula ed in PCa (Figu e 3C–3F), and 2 RFs (bo h om
he 3e- RF class) we e down egula ed (Figu e 3G–3H).
Speci ic RF signa u es can se e as p ognos ic
ma ke o ecu en p os a e cance
The exp ession le els o RFs selec ed o alida ion
by qPCR we e s udied in a coho o clinical samples
ob ained om E asmus MC, Ro e dam (coho 1) and
a coho o samples om Tampe e Uni e si y Hospi al,
Tampe e (coho 2). The NAP samples we e iden ical o
bo h coho s and we e p ocessed independen ly in coho
1 and coho 2 o accoun o echnical di e ences in
sample ea men . Using cus om designed p ime s, we
could de ec h ee RFs (Figu e 4A–4C). RF-544 (de i ed
om RNA
PheGAA
) was signi ican ly down egula ed in he
ecu en PCa compa ed o NAP o cu ed PCa in coho
1 (Figu e 4A). In coho 2, RF-544 was down egula ed
in PCa wi h Gleason sco e highe han 7 o in PCa
wi h pa hological s age 3 sugges ing associa ion wi h
agg essi e o la e s age disease. The di e en ial
exp ession o his RF was also con i med in a second deep
sequencing analysis o a sub-se o PCa samples om
Tampe e Uni e si y Hospi al (unpublished da a). RF-315
(de i ed om RNALysCTT) was signi ican ly up egula ed
in all PCa g oups o coho 2 (Figu e 4B). We could no
de ec s a is ically signi ican di e ence in he exp ession
o RF-315 in he smalle coho 1. Ne e heless, he e was
a clea end o RF-315 up egula ion in he PCa samples.
Onco a ge 24771
www.impac jou nals.com/onco a ge
RF-562 (de i ed om RNAGlyTCC) was signi ican ly
down egula ed in PCa ecu en s. NAP g oup in he
coho 1 and in he PCa pT3 s. NAP g oup in he coho
2 (Figu e 4C).
In e es ingly, RF-544 was consis en ly
down egula ed in samples om pa ien s ha de eloped
ecu en disease compa ed o samples om pa ien s
ha we e cu ed by adical p os a ec omy in bo h coho s.
Fu he mo e, RF-544 exp ession was lowe in high-
(Gleason sco e ≥7) compa ed o low-g ade (Gleason sco e
<7) umo s (Figu e 4A). Vice e sa, RF-315 demons a ed
a clea end o up egula ion in ecu en disease and i s
exp ession was highe in high-g ade umo s (Figu e 4B).
The e o e, we easoned ha he exp ession o hese wo
RFs migh be p ognos ic o agg essi e umo g ow h
and disease ecu ence a e adical p os a ec omy. We
ook ad an age o he opposing exp ession pa e ns o
hese wo RFs and calcula ed he exp ession a io RF-
315/ RF-544 o bo h coho s (Figu e 4D). The RF-315/
RF-544 a io showed signi ican di e ences, clea ly
dis inguishing high om low g ade PCa and cu ed om
ecu en disease. Mo eo e , high exp ession a io was
signi ican ly associa ed wi h poo e p og ession- ee
su i al and sho e pe iod o disease elapse (Figu e 4E),
sugges ing ha he RF-315/ RF-544 a io migh ep esen
a help ul clinical bioma ke o disease p og ession.
Figu e 2: Di e en ially exp essed RFs in p os a e cance . Plo ed a e no malized ead-coun alues o each RF in he no mal
adjacen p os a e e sus a ious s ages o p os a e cance . The baseline alue o RFs ha a e no exp essed is 1. Full lines ep esen 4- old
change bo de lines. Colo ed poin s ep esen signi ican ly changed RFs (Kal’s Z- es on p opo ions, Bon e oni co ec ed p- alues, p <
0.05) labeled as 5’-de i ed (magen a) and 3’-de i ed (g een) RFs. RFs wi h he 3’-nucleo ide a a posi ion ≤40 on he p ecu so RNA
sequence a e conside ed as 5′-de i ed. RFs wi h he s a nucleo ide a a posi ion ≥30 on he p ecu so RNA sequence a e conside ed
as 3′-de i ed. RFs ha do no all in o ei he o hese wo ca ego ies a e shown in blue. Posi ions o RF-310, RF-315, and RF-389
a e indica ed as an example o h ee di e en ially exp essed RFs. The g aph a he bo om igh co ne summa izes he o al numbe o
di e en ially exp essed RFs pe g oup. The amoun o RFs wi h ≥4- old di e en ial exp ession a e indica ed in da k o ange (up egula ed)
o da k blue (down egula ed) colo .
Onco a ge 24772
www.impac jou nals.com/onco a ge
DISCUSSION
The echnical p og ess in sequencing echnologies
and he apid inc ease in he numbe o s udies on
sncRNA led o he disco e ies o no el small RNA classes
including RFs. Since hei ini ial iden i ica ion, RFs ha e
been desc ibed in a ple ho a o species and knowledge
abou hei unc ion in he cell is s a ing o accumula e.
Al hough se e al s udies desc ibe exp ession o RFs in
human cell lines, hei ac ual epe oi e in human issues
emains la gely unknown [5, 15, 16, 22].
He e, we s udied he composi ion and exp ession
o RFs in clinical PCa samples ep esen ing p og essing
disease s ages. We ound ha all cy osolic RNAs
p oduced RFs in he size ange o 18-21 n , ep esen ing
he small class o RFs. The longe RNA hal es we e no
as common, which is a consequence o he size selec ion
(~15-35 n ) applied o he isola ion o sncRNAs ac ion
in ou s udy. We ound a signi ican bu weak co ela ion
be ween he exp ession o RFs pe RNA and he codon
usage o RNAs, sugges ing ha al hough RF exp ession
is dependen on he exp ession le els o hei p ecu so s,
mos likely addi ional mechanisms con ol RF le els in
he cell.
The accu a e quan i ica ion o agmen s de i ed
om small RNAs in RNA sequencing da a equi es a
p ecise anno a ion o he exac posi ion o he agmen
on i s p ecu so ansc ip . To p edic he loca ions o
RFs and quan i y hei exp ession we used he p og ams
FlaiMappe and CLC-Bio Genomics Wo kbench [23]. We
Figu e 3: F equency o RF ypes among di e en ially exp essed RFs. A-B. S a (blue line) and end (o ange line) posi ions
o RFs on he ma u e RNA sequence and he p opo ions o each RF ype o 72 up egula ed (A) and 24 down egula ed (B) RFs. C-H.
G aphs showing he exac posi ions o 6 selec ed RFs (shown in colo ) and o he RFs (shown in g ey) on hei RNA p ecu so s. The
x-axis ep esen s he posi ion on he p ecu so sequence in nucleo ides. The y-axis ep esen s summed ead-coun s pe sample g oup. The
exp ession le el pe g oup is indica ed by di e en colo (see he legend a he bo om). Exp ession le els o o he RFs a e shown as means
ac oss PCa g oups.
Onco a ge 24773
www.impac jou nals.com/onco a ge
iden i ied 598 unique RFs de i ed om ma u e RNAs.
Based on he pa o ma u e RNA om which agmen s
o igina e, we could dis inguish 5 di e en RF classes.
Ou o hese, he 5e- RFs class was he mos abundan
o all and con ained he highes numbe o unique RFs.
This inding is in ag eemen wi h o he epo s showing
highe abundance o 5’-end de i ed RFs [4, 5, 22, 32–
34]. Gi en he ole o 5’-de i ed RFs in he inhibi ion
o p o eosyn hesis and hei ole in he assembly o s ess
g anules, a ype o s ess-induced cy oplasma ic oci wi h
high concen a ion o un ansla ed mRNPs [10, 19, 30],
i would be in e es ing o es hei po en ial o inhibi
ansla ion and induce he assembly o s ess g anules
in i o in PCa cell lines using he se o up egula ed
5’-de i ed RFs iden i ied in ou s udy. The impo ance
o RFs in s ess g anule assembly becomes e en mo e
in iguing hanks o he la es indica ions ha s ess
g anules migh play an impo an ole in cance ia
he nega i e egula ion o mTORC1-hype ac i a ion-
induced apop osis [35]. This sugges s ha up egula ion o
RFs migh be indi ec ly linked wi h he supp ession o
apop osis in cance cells.
Ou disco e y coho included pa ien -de i ed PCa
samples wi h di e en clinico-pa hological cha ac e is ics.
The majo di e ence in RF exp ession (a leas 110 unique
di e en ially exp essed RFs) was obse ed be ween NAP
and PCa issue indica ing ha global up egula ion o RF
p oduc ion is associa ed wi h malignan ans o ma ion.
In e es ingly, 5e- RFs we e he p edominan class
up egula ed in PCa. Recen ly, 5’- RFs we e ound o
induce ansla ional inhibi ion in siRNA-independen way
[36]. I was shown ha he ep essing ac i i y o 5’-de i ed
Figu e 4: qPCR alida ion o RF-544, RF-315, and RF-562. A-C. RNA exp ession o RF-544 (A), RF-315 (B), and RF-562
(C) in coho s o clinical samples ob ained om E asmus MC (coho 1) and Tampe e Uni e si y Hospi al (coho 2). Mean alues a e
indica ed by a ed line. D. Ra io o RF-315 (de i ed om RNALysCTT) o RF-544 (de i ed om RNAPheGAA). E. P og ession- ee su i al
cu es o coho 1 and coho 2 based on he RF-315/ RF544 a io. Legend: NAP, no mal adjacen p os a e; PCa, p os a e cance ; PCa
cu (PCa cu ed), pa ien s wi h no disease ecu ence a e adical p os a ec omy; PCa ecu (PCa ecu en ), pa ien s wi h biochemical
ecu ence o me as a ic p og ession a e adical p os a ec omy; Gl <7, Gleason sco e <7; Gl ≥7, Gleason sco e 7, 8 o 9; pT2, pa hological
s age 2; pT3, pa hological s age 3; *P- alue ≤0.05; **P- alue ≤0.01; ***P- alue ≤0.001.
Onco a ge 24774
www.impac jou nals.com/onco a ge
RFs was dependen on he p esence o a conse ed “GG”
dinucleo ide a hei 3’-end, which is a common ea u e o
~75% o he up egula ed 5e- RFs desc ibed in his s udy.
Compa ing ou da a se wi h an ex e nal RF da a se
o PCa cell lines gene a ed by Lee e al. [5] demons a ed
ha all RFs o igina ing om 3’-p e- RNA aile s and 32
ou o 36 5’- RFs desc ibed by Lee e al. we e de ec ed
in ou s udy. This sugges s ha RFs in p os a e (cance )
issue and cell lines a e common and disc e e biological
en i ies p oduced by de ined molecula mechanisms. Fo
3’-de i ed RFs we ound a small o e lap o only 6 ou o
77 RFs. A possible eason o ha could be ha 3’-de i ed
RFs ep esen a class o RFs wi h a less s able exp ession.
On he o he hand, ou esul s demons a e ha mos o
he down egula ed RFs a e 3e- RFs, which migh be a
gene al ea u e o PCa and PCa cell lines. I ha is he case,
he limi ed o e lap o 3’-de i ed RFs be ween bo h da a
se s migh be caused by he less eliable de ec ion o low
exp essed ansc ip s. Down egula ion o 3’-de i ed RFs
migh be an impo an e en in he onse o cance [21].
Possible unc ional implica ions o 3’- RF down egula ion
in PCa can be de i ed om he demons a ed in ol emen
o he 3′-de i ed RF CU1276 in B-cell lymphoma cells,
which supp esses p oli e a ion and modula es he esponse
o DNA damage [21]. Ano he ecen s udy in b eas
cance desc ibed se e al RFs wi h umo supp esso
unc ion ha o igina e om RNAGlyTCC, RNAGluYTC,
RNAAspGTC, and RNATy GTA [15]. Upon induc ion in b eas
cance cells, hese RFs supp ess he s abili y o mul iple
oncogenic ansc ip s by sequence speci ic displacemen
o hei 3′-UTRs om he RNA-binding p o ein YBX1. I
can be assumed ha down egula ion o such RFs would
lead o cance p og ession. In e es ingly, some o he
down- egula ed 3’- RFs (e.g. RF-562 and RF-542) in ou
sequencing lib a ies o igina e om he same RNAs. Fu u e
in es iga ions should add ess he unc ional implica ions
on gene egula ion in PCa caused by down egula ion o
3’-de i ed RFs and in pa icula RF-544.
Due o high conse a ion o RNAs we we e
unable o iden i y speci ic sequences ha would se e
as a ecogni ion si e o RNA nucleases ha disc imina e
and p e e ably clea e pa icula RNAs. Recen ly, i was
p oposed ha ce ain RNAs swi ch om canonical o
al e na i e olding and he abili y o do so migh cause
he speci ic up egula ion o hei RFs. Fo example,
besides he canonical clo e lea s uc u e, RNAIle has
he po en ial o o m a long hai pin [37]. RNAAsp also
adop s an al e na i e olding in o de o bind o he Alu
elemen inse ion in he 3’-UTR o he mRNA o i s
own aminoacyl- RNA syn he ase [38]. Since nucleo ide
modi ica ions a e known o a ec hyb idiza ion, i is
emp ing o specula e o wha ex end hey a ec he
al e na i e olding o RNAs [39].
Finally, q-PCR analysis o RFs di e en ially
exp essed in di e en g ade PCa demons a ed ha he
exp ession a io RF-544, de i ed om RNA
PheGAA
and RF-
315 de i ed om RNALysCTT e ec i ely disc imina es high
om low g ade p os a e umo s and cu ed om ecu en
disease. This es ablishes RFs as no el candida e bioma ke s
o he ea ly de ec ion o ecu en agg essi e PCa.
In conclusion, ou s udy p o ides a comp ehensi e
ca alogue o RFs exp essed in a ious s ages o PCa and
p o ides leads o he u he in es iga ion o biological
ole and ma ke po en ial o hese no el RNA en i ies in
p os a e cance .
MATERIALS AND METHODS
Sample coho s and p ocessing
The disco e y se used in his s udy consis s o 10
sequencing lib a ies gene a ed as p e iously desc ibed
[24]. B ie ly, each lib a y was cons uc ed om a o al
RNA pool p epa ed om ou indi idual pa ien samples
wi h simila pa hological o gene ic cha ac e is ics [40].
Di e en g oups ep esen : no mal adjacen p os a e
issue (NAP), p os a e umo s wi h Gleason sco e 6, 7, o
8 (PCa6, PCa7, PCa8), me as a ic lymph nodes (LN_PCa),
all ob ained by adical p os a ec omy; benign p os a e
hype plasia issue (BPH) ob ained by cys op os a ec omy;
and cas a ion esis an p os a e umo s ob ained by ans-
u e h al esec ion o he p os a e (TURP_PCa) [24]. The
clinical pa ame e s o each g oup a e summa ized in he
Table 1. PCa g oups wi h Gleason sco e 6 we e di ided
in o cu ed and ecu en disease g oups o in o g oups wi h
o wi hou TMPRSS2-ERG usion o ETV abno mali ies.
Sample ma e ial was ob ained om he issue banks o
he E asmus Uni e si y Medical Cen e , Ro e dam,
The Ne he lands (E asmus MC, Ro e dam, The
Ne he lands) and Tampe e Uni e si y Hospi al (TAUH,
Tampe e, Finland). Collec ion and use o pa ien ma e ial
was pe o med acco ding o he na ional legisla ions
conce ning e hical equi emen s and app o ed by he
E asmus MC Medical E hics Commi ee acco ding o he
Medical Resea ch In ol ing Human Subjec s Ac (MEC-
2004- 261), and he E hical Commi ee o he Tampe e
Uni e si y Hospi al. Samples we e snap ozen and s o ed
in liquid ni ogen. Gleason sco e and he pe cen age
o no mal and cance epi helial cells we e e alua ed
om his ological sec ions by wo pa hologis s. Only
samples wi h mo e han 70% o umo cells we e used
o sequencing lib a y p epa a ion. All samples ha we e
used o he no mal p os a e pool con ained 0% o umo
cells. To al RNA was ex ac ed using RNABee eagen
(Camp o Scien i ic, GmbH, Be lin, Ge many) acco ding
o he manu ac u e ’s p o ocol.
qPCR alida ion was pe o med in wo
sepa a e coho s. Clinical pa ame e s a e p o ided in
Supplemen a y Tables 6-7). The i s coho (coho 1)
consis s o 65 samples ob ained om E asmus MC.
The samples we e collec ed, handled and e alua ed as
men ioned in he p e ious pa ag aph. The second coho
(coho 2) consis s o 104 ho monally un ea ed p ima y
p os a e umo s om adical p os a ec omy specimens